2025年全球α发射体市场报告

预计未来几年α发射体市场规模将呈指数级增长。到 2029 年，这一数字将成长至 37.3 亿美元，年复合成长率（CAGR）为 23.4%。预测期内的成长归因于医疗保健支出的增加、心臟疾病患者数量的增加、联合治疗的增加、标靶阿尔法疗法的广泛使用以及研发活动的活性化。预测期内的关键趋势包括成像技术的进步、产品创新、策略联盟、放射性药物开发的进步以及新型α发射同位素的开发。

预计未来癌症发生率的上升将推动α发射体市场的成长。癌症是一种以异常细胞不受控制地生长和扩散为特征的疾病，异常细胞会形成肿瘤并侵入附近组织。导致癌症扩散的因素包括人口老化、环境暴露、生活方式的改变和检测方法的改进。阿尔法发射体用于癌症治疗，以精确瞄准和摧毁癌细胞，同时最大限度地减少对周围健康组织的伤害。例如，2023年8月，澳洲政府卫生机构澳洲健康与福利研究所预测，被诊断出罹患癌症（不包括皮肤基底细胞癌和鳞状细胞癌）的美国人数量将从2021年的151,000人增加到2030年的185,000人。因此，癌症盛行率的上升正在推动α发射体市场的成长。

阿尔法发射体市场的主要企业正专注于投资迴旋加速器生产的阿尔法发射体等创新解决方案，以获得竞争优势。这些放射性核种是放射性同位素，崩坏时会释放出阿尔法粒子，是透过在迴旋加速器中将带电粒子加速到高能量而产生的。例如，2023年4月，美国迴旋加速器技术公司Ionetix在其位于密西根州兰辛的新α同位素生产设施中生产出第一个发射α核素砹-211（At-211）。该设施是美国第一座专门利用迴旋加速器技术生产阿尔法发射核素的设施。此次生产得益于一台 30 MeV 迴旋加速器的试运行，该加速器旨在加速 α 粒子以高产量生产 At-211 和锕-225 (Ac-225)。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球α发射体PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
• 最终用途产业分析
• 全球α发射体市场：成长率分析
• 全球α发射体市场表现：规模与成长，2019-2024
• 全球α发射体市场预测：规模与成长，2024-2029 年，2034 年
• 全球α发射体总可定址市场（TAM）

第六章市场区隔

• 全球α发射体市场（依放射性核种类型、实际及预测），2019-2024 年、2024-2029 年、2034 年
• 镭
• 锟
• 带领
• 铋
• 其他类型的放射性核种
• 全球α发射体市场（按来源、性能和预测），2019-2024 年、2024-2029 年、2034 年
• 自然资源
• 人工生成的辐射源
• 其他资讯来源
• 全球α发射体市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 胰臟癌
• 卵巢癌
• 摄护腺癌
• 淋巴瘤
• 黑色素瘤
• 骨转移
• 其他用途
• 全球α发射体市场：按最终用户、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 医院
• 医学研究所
• 其他最终用户
• 全球α发射体市场镭细分市场（按类型、实际及预测），2019-2024 年、2024-2029 年、2034 年
• 镭223
• 镭226
• 镭228
• 全球α发射体市场锕类细分市场（按类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
• 锕-227
• 锕225
• 全球α发射体市场主要细分市场（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
• 铅-210
• 铅-212
• 全球α发射体市场细分（按类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
• 铋213
• 铋212
• 全球α发射体市场、其他类型放射性核种细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
• 钍
• 钋
• 鍅

第七章 区域和国家分析

• 全球α发射体市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球α发射体市场：依国家、地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

• α发射体市场：竞争格局
• α发射体市场：公司简介
  • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Curium Pharma Overview, Products and Services, Strategy and Financial Analysis
  • Eckert & Ziegler BEBIG GmbH Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Telix Pharmaceuticals Limited
• NorthStar Medical Radioisotopes LLC
• ITM Isotope Technologies Munich SE
• Blue Earth Diagnostics Ltd.
• International Isotopes Inc.
• IBA Radiopharma Solutions
• Orano Med LLC
• ARTbio AS
• Actinium Pharmaceuticals Inc.
• Clarity Pharmaceuticals Ltd.
• RadioMedix Inc.
• Nordic Nanovector ASA
• Convergent Therapeutics
• TAE Life Sciences
• ABX-CRO advanced pharmaceutical services Forschungsgesellschaft mbH

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029 年α发射体市场：提供新机会的国家
• 2029 年α发射体市场：细分市场带来新机会
• 2029 年α发射体市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第36章 附录

An alpha emitter is a type of radioactive substance that releases alpha particles during radioactive decay. It includes elements, such as uranium, radium, and plutonium, that undergo alpha decay as part of their natural radioactive processes. Alpha emitters play a significant role in medical treatments, especially cancer therapy, and in various technological applications such as smoke detectors and space exploration.

The main types of radionuclide of alpha emitters are radium, actinium, lead, bismuth, and others. Radium is a radioactive element used in medical treatments and diagnostic procedures. The source is natural sources, artificially produced sources, and others, and applications are pancreatic cancer, ovarian cancer, prostate cancer, lymphoma, melanoma, bone metastasis, and others. It is used by various end-users such as hospitals, medical research institutions, and others.

The alpha emitter market research report is one of a series of new reports from The Business Research Company that provides alpha emitter market statistics, including alpha emitter industry global market size, regional shares, competitors with a alpha emitter market share, detailed alpha emitter market segments, market trends and opportunities, and any further data you may need to thrive in the alpha emitter industry. This alpha emitter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The alpha emitter market size has grown exponentially in recent years. It will grow from $1.3 $ billion in 2024 to $1.61 $ billion in 2025 at a compound annual growth rate (CAGR) of 23.7%. The growth in the historic period can be attributed to increasing incidence of cancer, growing research investments, government support and funding, rising aging population, and expansion of radiotherapy centers.

The alpha emitter market size is expected to see exponential growth in the next few years. It will grow to $3.73 $ billion in 2029 at a compound annual growth rate (CAGR) of 23.4%. The growth in the forecast period can be attributed to rising medical expenditure, the growing number of patients with cardiac ailments, growing use of combination therapies, the increasing prevalence of targeted alpha therapy, and increasing research and development activities. Major trends in the forecast period include advancements in imaging technologies, product innovations, strategic collaboration, advancements in radiopharmaceutical development, and development of new alpha-emitting isotopes.

The rising prevalence of cancer is anticipated to drive the growth of the alpha emitter market in the future. Cancer is a disease marked by the uncontrolled proliferation and spread of abnormal cells, which can form tumors and invade nearby tissues. Contributing factors to cancer prevalence include aging populations, environmental exposures, lifestyle changes, and improved detection methods. Alpha emitters are utilized in cancer treatment to target and destroy tumor cells with high precision, while minimizing harm to surrounding healthy tissues. For example, in August 2023, the Australian Institute of Health and Welfare, an Australian government health administration, projected that the number of Americans diagnosed with cancer (excluding basal cell carcinomas and squamous cell carcinomas of the skin) will rise from 151,000 in 2021 to 185,000 by 2030. Consequently, the increasing prevalence of cancer is fueling the growth of the alpha emitter market.

Major companies in the alpha-emitter market are focusing on investing in innovative solutions, such as alpha-emitting radionuclides produced using cyclotrons, to gain a competitive edge. These radionuclides are radioactive isotopes that emit alpha particles during decay and are created by accelerating charged particles to high energies in a cyclotron. For example, in April 2023, Ionetix, a US-based cyclotron and technology company, produced its first alpha-emitting radionuclide, Astatine-211 (At-211), at its newly established Alpha Isotope Manufacturing facility in Lansing, Michigan. This facility is notable as the first in the U.S. dedicated exclusively to producing alpha-emitting radionuclides using cyclotron technology. The production was made possible by commissioning a 30 MeV cyclotron, designed to accelerate alpha particles for the high-yield production of At-211 and Actinium-225 (Ac-225).

In February 2024, Bristol-Myers Squibb Co. (BMS), a US-based biopharmaceutical company, acquired RayzeBio, Inc. for $4.1 billion. This acquisition allows Bristol-Myers Squibb to enhance its oncology portfolio by integrating innovative radiopharmaceutical therapies, particularly targeted alpha-emitter treatments. RayzeBio, Inc. is a US-based provider specializing in alpha emitters.

Major companies operating in the alpha emitter market are Cardinal Health Inc., Bayer AG, Lantheus Holdings Inc., Curium Pharma, Eckert & Ziegler BEBIG GmbH, Telix Pharmaceuticals Limited, NorthStar Medical Radioisotopes LLC, ITM Isotope Technologies Munich SE, Blue Earth Diagnostics Ltd., International Isotopes Inc., IBA Radiopharma Solutions, Orano Med LLC, ARTbio AS, Actinium Pharmaceuticals Inc., Clarity Pharmaceuticals Ltd., RadioMedix Inc., Nordic Nanovector ASA, Convergent Therapeutics, TAE Life Sciences, ABX-CRO advanced pharmaceutical services Forschungsgesellschaft mbH, Fusion Pharmaceuticals Inc.

North America was the largest region in the alpha emitter market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the alpha emitter market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the alpha emitter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The alpha emitter market consists of sales of Plutonium-238 (Pu-238), Thorium-227 (Th-227), Polonium-210 (Po-210), and Americium-241 (Am-241). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Alpha Emitter Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on alpha emitter market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for alpha emitter ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The alpha emitter market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type Of Radionuclide: Radium; Actinium; Lead; Bismuth; Other Types Of Radionuclides
• 2) By Source: Natural Sources; Artificially Produced Sources; Other Sources
• 3) By Application: Pancreatic Cancer; Ovarian Cancer; Prostate Cancer; Lymphoma; Melanoma; Bone Metastasis; Other Applications
• 4) By End-User: Hospitals; Medical Research Institutions; Other End-Users
• Subsegments:
• 1) By Radium: Radium-223; Radium-226; Radium-228
• 2) By Actinium: Actinium-227; Actinium-225
• 3) By Lead: Lead-210; Lead-212
• 4) By Bismuth: Bismuth-213; Bismuth-212
• 5) By Other Types of Radionuclides: Thorium; Polonium; Francium
• Companies Mentioned: Cardinal Health Inc.; Bayer AG; Lantheus Holdings Inc.; Curium Pharma; Eckert & Ziegler BEBIG GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Alpha Emitter Market Characteristics

3. Alpha Emitter Market Trends And Strategies

4. Alpha Emitter Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Alpha Emitter Growth Analysis And Strategic Analysis Framework

• 5.1. Global Alpha Emitter PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Alpha Emitter Market Growth Rate Analysis
• 5.4. Global Alpha Emitter Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Alpha Emitter Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Alpha Emitter Total Addressable Market (TAM)

6. Alpha Emitter Market Segmentation

• 6.1. Global Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radium
• Actinium
• Lead
• Bismuth
• Other Types Of Radionuclides
• 6.2. Global Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Sources
• Artificially Produced Sources
• Other Sources
• 6.3. Global Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pancreatic Cancer
• Ovarian Cancer
• Prostate Cancer
• Lymphoma
• Melanoma
• Bone Metastasis
• Other Applications
• 6.4. Global Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Medical Research Institutions
• Other End-Users
• 6.5. Global Alpha Emitter Market, Sub-Segmentation Of Radium, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radium-223
• Radium-226
• Radium-228
• 6.6. Global Alpha Emitter Market, Sub-Segmentation Of Actinium, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Actinium-227
• Actinium-225
• 6.7. Global Alpha Emitter Market, Sub-Segmentation Of Lead, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lead-210
• Lead-212
• 6.8. Global Alpha Emitter Market, Sub-Segmentation Of Bismuth, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bismuth-213
• Bismuth-212
• 6.9. Global Alpha Emitter Market, Sub-Segmentation Of Other Types of Radionuclides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thorium
• Polonium
• Francium

7. Alpha Emitter Market Regional And Country Analysis

• 7.1. Global Alpha Emitter Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Alpha Emitter Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Alpha Emitter Market

• 8.1. Asia-Pacific Alpha Emitter Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Alpha Emitter Market

• 9.1. China Alpha Emitter Market Overview
• 9.2. China Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Alpha Emitter Market

• 10.1. India Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Alpha Emitter Market

• 11.1. Japan Alpha Emitter Market Overview
• 11.2. Japan Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Alpha Emitter Market

• 12.1. Australia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Alpha Emitter Market

• 13.1. Indonesia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Alpha Emitter Market

• 14.1. South Korea Alpha Emitter Market Overview
• 14.2. South Korea Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Alpha Emitter Market

• 15.1. Western Europe Alpha Emitter Market Overview
• 15.2. Western Europe Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Alpha Emitter Market

• 16.1. UK Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Alpha Emitter Market

• 17.1. Germany Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Alpha Emitter Market

• 18.1. France Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Alpha Emitter Market

• 19.1. Italy Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Alpha Emitter Market

• 20.1. Spain Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Alpha Emitter Market

• 21.1. Eastern Europe Alpha Emitter Market Overview
• 21.2. Eastern Europe Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Alpha Emitter Market

• 22.1. Russia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Alpha Emitter Market

• 23.1. North America Alpha Emitter Market Overview
• 23.2. North America Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Alpha Emitter Market

• 24.1. USA Alpha Emitter Market Overview
• 24.2. USA Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Alpha Emitter Market

• 25.1. Canada Alpha Emitter Market Overview
• 25.2. Canada Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Alpha Emitter Market

• 26.1. South America Alpha Emitter Market Overview
• 26.2. South America Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Alpha Emitter Market

• 27.1. Brazil Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Alpha Emitter Market

• 28.1. Middle East Alpha Emitter Market Overview
• 28.2. Middle East Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Alpha Emitter Market

• 29.1. Africa Alpha Emitter Market Overview
• 29.2. Africa Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Alpha Emitter Market Competitive Landscape And Company Profiles

• 30.1. Alpha Emitter Market Competitive Landscape
• 30.2. Alpha Emitter Market Company Profiles
  • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Curium Pharma Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eckert & Ziegler BEBIG GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Alpha Emitter Market Other Major And Innovative Companies

• 31.1. Telix Pharmaceuticals Limited
• 31.2. NorthStar Medical Radioisotopes LLC
• 31.3. ITM Isotope Technologies Munich SE
• 31.4. Blue Earth Diagnostics Ltd.
• 31.5. International Isotopes Inc.
• 31.6. IBA Radiopharma Solutions
• 31.7. Orano Med LLC
• 31.8. ARTbio AS
• 31.9. Actinium Pharmaceuticals Inc.
• 31.10. Clarity Pharmaceuticals Ltd.
• 31.11. RadioMedix Inc.
• 31.12. Nordic Nanovector ASA
• 31.13. Convergent Therapeutics
• 31.14. TAE Life Sciences
• 31.15. ABX-CRO advanced pharmaceutical services Forschungsgesellschaft mbH

32. Global Alpha Emitter Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Alpha Emitter Market

34. Recent Developments In The Alpha Emitter Market

35. Alpha Emitter Market High Potential Countries, Segments and Strategies

• 35.1 Alpha Emitter Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Alpha Emitter Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Alpha Emitter Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer